Infantile epileptic syndromes and metabolic etiologies

Related Experiment Video

Updated: Sep 14, 2026

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Federico Vigevano1, Andrea Bartuli

  • 1Division of Neurology, Bambino Gesù Children's Hospital, Rome, Italy. vigevano@opbg.net

Journal of Child Neurology
|February 25, 2003
PubMed

Insights

Inherited metabolic disorders are a key cause of early-onset epilepsy, often presenting with varied neurological symptoms beyond seizures. Early diagnosis is crucial for managing these complex conditions.

Area of Science:

  • Neurology
  • Metabolic Disorders
  • Epileptology

Background:

  • Inherited metabolic disorders (IMDs) are a significant cause of epilepsy in infants.
  • Epilepsy is often not the primary symptom, with other neurological issues like developmental delay being more prominent.
  • The mechanisms of seizures in IMDs are diverse, involving neurotransmitter imbalance, energy deficits, or brain malformations.

Purpose of the Study:

  • To highlight the crucial role of IMDs in early-onset epilepsy.
  • To discuss the varied clinical presentations and diagnostic challenges.
  • To emphasize the need for considering IMDs in epilepsy cases with neurological decline.

Main Methods:

  • Review of clinical presentations and electroencephalogram (EEG) findings in epilepsy secondary to IMDs.
  • Analysis of established and emerging etiological pathways for seizures in IMDs.
  • Correlation of specific clinical signs with particular metabolic causes.

Main Results:

  • While some IMDs have characteristic epilepsy syndromes (e.g., pyridoxine-dependent seizures), most present with diverse and difficult-to-classify clinical and EEG features.
  • Common seizure characteristics include early onset, partial and multifocal seizures, and resistance to standard antiepilepsy drugs.
  • Specific clinical clues can suggest certain metabolic etiologies.

Conclusions:

  • IMDs should be strongly considered in infants with epilepsy, especially when accompanied by progressive neurological worsening.
  • Recognizing specific clinical and EEG patterns can aid in identifying certain metabolic causes.
  • A comprehensive approach is needed for diagnosing and managing epilepsy in the context of IMDs.

More Related Videos

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice09:29

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice

Published on: June 11, 2020

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.